Study on the health effects of population selenium intervention

Natural Biofortification Program

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000040987

Enrollment

Unknown

Registered

2020-12-16

Start date

2021-01-01

Completion date

Unknown

Last updated

2021-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Selenium Deficiency

Interventions

Control group:intake 50 µg/d by selenium tablets

Low selenium group :intake 50 µg/d by selenium tablets

Medium selenium group :intake 100 µg/d by selenium tablets

High selenium group :intake 200 µg/d by selenium tablets

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: People Come from other places (Shanghai, Suzhou, etc.) and plan to live in Wentang for three months or more.

Exclusion criteria

Exclusion criteria: Suffer from major basic diseases, such as cancer and tumor; have been taking selenium supplementation for a long time before recruitment (referring to the consumption of special supplements such as selenium tablets).

Design outcomes

Primary

Measure	Time frame
selenium in the hair;selenium in the blood;	—

Countries

China

Contacts

Public ContactHuang Lei

High-Tech Research Institute of Nanjing University (Suzhou)

huanglei@nju.edu.cn+86 13218881515

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026